25 May 2023
A possible vaccine for elevated cholesterol is set to be trialled in Moreton Bay at the University of the Sunshine Coast.
The trial, sponsored by biotech company Vaxxinity based in the United States, is a “phase one” trial to test the safety and effectiveness of the vaccine in people with elevated cholesterol, and will take place at UniSC Clinical Trials in Moreton Bay.
The team is now on the lookout for participants who meet the study’s eligibility criteria to attend the trial at the state-of-the-art Health Hub Doctors Morayfield facility.
Principal Investigator on the project Dr Chris Moller said the investigational medication had been developed to help prevent heart disease caused by elevated cholesterol.
“This is an opportunity to help us find a vaccine for elevated cholesterol, potentially preventing the establishment of heart disease in people who may be at risk of the condition,” Dr Moller said.
“Low-density lipoprotein-cholesterol (LDL-C), also known as “bad” cholesterol, can cause plaque to build up inside arteries and lead to heart disease.
“Decreasing and maintaining low levels of LDL-C can reduce the risk and help prevent heart disease in the long-term.”
The UniSC Clinical Trials team is looking for individuals aged between 18 and 75-years-old with elevated cholesterol who are not currently taking any prescribed medication to control it.
Eligible participants will be required to attend approximately 14 visits, plus eight phone calls, at the Morayfield clinic over the course of around 34 weeks.
Those interested in volunteering can find more information at www.usc.edu.au/trials
Related articles

USC Clinical Trials seeks healthy volunteers for malaria study in Brisbane
6 Apr 2022USC Clinical Trials will partner with Geneva-based Medicines for Malaria Venture and QIMR Berghofer Medical Research Institute in Brisbane to test the activity of an antimalarial drug in humans who are infected with m

Community can help with next vaccines as flu reaches pre-pandemic levels
4 MayAs influenza infections in Australia return to pre-pandemic levels, the University of the Sunshine Coast Clinical Trials Centre seeking people to help with the development of the next generation of vaccines.

Clinical trial of an investigational medication for cognitive impairment due to depression
23 MarThe University of the Sunshine Coast is collaborating with an Australian biotechnology company to begin trials assessing a novel therapy for neurological diseases associated with dysregulated brain cortisol.